Moving the Needle on Metastatic Breast Cancer
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
Metastatic breast cancer remains incurable, but researchers’ understanding of the molecular features of the disease is leading to additional treatments.
A mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer.
Study finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
The FDA has approved capivasertib for the treatment of breast cancers with certain mutations. The U.S. Food and Drug Administration (FDA) has approved capivasertib (Truqap), in combination with fulvestrant (Faslodex), for the treatment of...
Lorazepam used to relieve stress may cause inflammation that promotes tumor growth and shortens progression-free survival, study says. A medication commonly used to ease the stress caused by cancer diagnosis and treatment may be...
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.